Objective To investigate the relationships of tumor necrosis factor-α (TNF-α) and glycated hemoglobin (HbA1c) with the occurrence of painful diabetic neuropathy (PDN) in patients with type 2 diabetes mellitus (T2DM).
Methods A total of 225 patients with T2DM were enrolled and divided into PDN group (52 patients) and non-PDN group (173 patients) based on the presence of PDN. Clinical data of the two groups were collected and compared. A multivariate Logistic regression model was used to analyze risk factors for PDN, and a receiver operating characteristic (ROC) curve was plotted to assess the predictive value of TNF-α and HbA1c for PDN in T2DM patients.
Results Patients in the PDN group had a longer duration of T2DM, higher levels of fasting blood glucose (FBG), HbA1c, C-reactive protein (CRP), and TNF-α compared with the non-PDN group (P < 0.05). Multivariate Logistic regression analysis showed that a longer duration of T2DM, higher TNF-α levels, and higher HbA1c levels were independent risk factors for PDN in T2DM patients (P < 0.05, OR>1). ROC curve analysis revealed that the area under the curve for the combined prediction of PDN in T2DM patients by TNF-α and HbA1c was 0.877(95%CI, 0.826 to 0.916), which was greater than that of TNF-α and HbA1c alone 0.684(95%CI, 0.619 to 0.745) and 0.764(95%CI, 0.703 to 0.818), respectively.
Conclusion High serum levels of TNF-α and HbA1c are independent risk factors for PDN in T2DM patients, and the combined detection of two biomarkers has high predictive efficacy for the risk of PDN in T2DM patients.
DownLoad: